These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 24606007

  • 1. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L, Liao A, Wen T, Yan L, Li B, Yang J.
    Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
    [Abstract] [Full Text] [Related]

  • 2. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria.
    Fan ST, Poon RT, Yeung C, Lam CM, Lo CM, Yuen WK, Ng KK, Liu CL, Chan SC.
    Br J Surg; 2011 Sep; 98(9):1292-300. PubMed ID: 21656513
    [Abstract] [Full Text] [Related]

  • 3. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW, Yi NJ, Suh KS.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [Abstract] [Full Text] [Related]

  • 7. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J.
    Br J Surg; 2007 Jan 27; 94(1):78-86. PubMed ID: 17016793
    [Abstract] [Full Text] [Related]

  • 8. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
    Moon JI, Kwon CH, Joh JW, Choi GS, Jung GO, Kim JM, Shin M, Choi SJ, Kim SJ, Lee SK.
    Transplant Proc; 2012 Mar 27; 44(2):487-93. PubMed ID: 22410053
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM, Kwon CH, Joh JW, Choi MS, Lee JH, Koh KC, Paik SW, Kim GS, Kim SJ, Lee SK, Yoo BC.
    Transplant Proc; 2012 Mar 27; 44(2):403-8. PubMed ID: 22410028
    [Abstract] [Full Text] [Related]

  • 10. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC, Chan SC, Chok KS, Cheung TT, Chiu DW, Poon RT, Fan ST, Lo CM.
    Liver Transpl; 2013 Apr 27; 19(4):411-9. PubMed ID: 23447460
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I.
    Liver Transpl; 2005 Oct 27; 11(10):1242-51. PubMed ID: 16184539
    [Abstract] [Full Text] [Related]

  • 14. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results.
    Di Sandro S, Giacomoni A, Slim A, Lauterio A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, De Carlis L.
    Hepatogastroenterology; 2012 Oct 27; 59(114):505-10. PubMed ID: 22353516
    [Abstract] [Full Text] [Related]

  • 15. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Liang W, Wu L, Ling X, Schroder PM, Ju W, Wang D, Shang Y, Kong Y, Guo Z, He X.
    Liver Transpl; 2012 Oct 27; 18(10):1226-36. PubMed ID: 22685095
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N, Shirabe K, Nakagawara H, Toshima T, Yamashita Y, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y.
    Transplantation; 2013 Dec 15; 96(11):1008-12. PubMed ID: 24113512
    [Abstract] [Full Text] [Related]

  • 17. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
    Lee KK, Kim DG, Moon IS, Lee MD, Park JH.
    J Surg Oncol; 2010 Jan 01; 101(1):47-53. PubMed ID: 19798686
    [Abstract] [Full Text] [Related]

  • 18. [Factors for predicting outcomes of liver transplantation and liver resection for hepatocellular carcinoma meeting Milan criteria].
    Huang J, Zhou J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar 01; 34(3):406-9. PubMed ID: 24670459
    [Abstract] [Full Text] [Related]

  • 19. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M, Shirabe K, Facciuto ME, Schwartz ME, Florman SS, Yoshizumi T, Harimoto N, Ikegami T, Uchiyama H, Maehara Y.
    J Am Coll Surg; 2015 Mar 01; 220(3):297-304.e3. PubMed ID: 25617912
    [Abstract] [Full Text] [Related]

  • 20. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
    Na GH, Kim EY, Hong TH, You YK, Kim DG.
    HPB (Oxford); 2016 Jan 01; 18(1):98-106. PubMed ID: 26776857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.